The FAMHP is ready for the Belgian presidency of the Council of the European Union

From 1 January to 30 June 2024, Belgium is holding the presidency of the Council of the European Union. The presidency in the area of public health will focus on three major themes: care, preparedness and protection. The FAMHP will use this opportunity to put our priorities on the European agenda and to help define European health policy for the coming years.

Jardiance (empagliflozin)

Active substance empagliflozin
Holder BOEHRINGER INGELHEIM Scomm
Status Running
Indication The use of Jardiance® in adults for the treatment of chronic kidney disease with an eGFR < 45 ml/min/1.73m² & uACR <200mg/g or with an eGFR ≥60 to <90 mL/min/1.73m2 in case of uACR ≥200 mg/g 
Public documents

Context

From 1 January to 30 June 2024, Belgium is holding the presidency of the Council of the European Union. The presidency of the Council rotates among European member states and changes every six months. Our role during the presidency is to coordinate the functioning of the Council and promote cooperation among member states.

Subscribe to